ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Is a Good Night's Sleep at the Top of Your Wishlist?

Ashwagandha Helps Hormones - Aids Arthritis

Why You Should Be Eating More Porcini Mushrooms

A Breathalyzer for Disease?

Tryptophan's Possible Effects for Your Health

How Bacopa Can Help Improve Your Cognitive Function

Black Tea Is Great for Your Gut

Magnesium Reduces Diabetes and Helps Keep You Young

Lavender Aromatherapy Can Ease Pre-Op Anxiety

Mint: Learn More About This Refreshing and Invigorating Herb

 
Print Page
Email Article

Slides of Ampligen® Trial Results Used in Presentation at IACFS/ME Conference

  [ 2 votes ]   [ Discuss This Article ]
www.ProHealth.com • March 19, 2009


Ampligen® is an investigational, intravenously delivered drug that has been tested in clinical trials involving ‘chronic fatigue syndrome’ (ME/CFS) patients for years. It is classified as a toll-like receptor (TLR) activator, which means its mode of action would be as an agent that activates TLRs to induce immune cell responses to pathogens.

Ampligen’s maker, Hemispherx Biopharma (HB), awaits the FDA’s decision on its New Drug Application, due May 25. And recently HB's Medical Director, Dr. David Strayer, presented the latest trial findings at the 2009 IACFS/ME Conference (Mar 12-15) in Reno. The trial involved patients treated at 12 clinical sites in the U.S.

You can now click through the slides Dr. Strayer used in this presentation, at HB’s website (www.hemispherx.net). (At the same time you will hear audio, not linked to the slides, from a webcast the company held Thursday Mar 19 to discuss its year-end 2008 results.) You’ll have a choice of versions employing Windows Media Player or RealPlayer.

The Title of the Slide Presentation:
“Interferon and Cytokine Levels in a Double-blind, Randomized, Placebo-controlled Phase III Clinical trial (AMP-516) of Poly I: Poly C12U (Ampligen®) in CFS.”

Authors: Strayer DR, Stouch BC, Horvath JC, Stevens SR, Carter WA. Hemispherx Biopharma Inc., Philadelphia, Pennsylvania; University of the Pacific, Stockton, California.

Investigators at the 12 sites: Drs. Bateman, Bellesorte, Cimoch, John, Keller, Lapp, Mercandetti, Peterson, Papernick, Podell, Stein, Taylor.

A Few Notes:
• Trial subjects were diagnosed with CFS, duration at least 12 months, and fell between 40 and 60 on the Karnofsky scale of functional impairment.

• Ampligen (or placebo) was delivered via IV infusions lasting about 30 minutes, twice weekly for 40 weeks.

Measured results included:
- Treadmill test of peak exercise duration
- Change from initial use of concomitant medications related to CFS

Mean (average) results for exercise duration (change from baseline to week 40):
- For those receiving Ampligen - improvement from 576 seconds to 672 seconds.
- For those receiving placebo – improvement from 588 seconds to 616 seconds.

More specifically, the mean percent of subjects who improved exercise duration:
- At least 25% - was 39% with Ampligen, vs. 23% with placebo
- At least 50% - was 26% with Ampligen, vs. 14% with placebo

Decrease in use of medications (decrease in number of days individual medications were taken during weeks 36-40 of study vs weeks 1-4):
- 72% of Ampligen group reduced medication use, vs. 56% of placebo group
- 26% of Ampligen group did not decrease med use, vs. 44% of placebo group

* * * *

Visit www.hemispherx.net for more detail.




Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Mitochondria Ignite™ with NT Factor® Ultra ATP+, Double Strength


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Help for Soreness and Swelling: What Do Silkworms Have to Do With It? Help for Soreness and Swelling: What Do Silkworms Have to Do With It?
The Surprising Benefits of Probiotics - What You Didn't Know The Surprising Benefits of Probiotics - What You Didn't Know
Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial
How to Jump-start and Sustain Energy Production in CFS How to Jump-start and Sustain Energy Production in CFS
Bone Broth Benefits for Digestion, Arthritis and Cellulite Bone Broth Benefits for Digestion, Arthritis and Cellulite

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map